Genistein in the Metabolic Syndrome: Results of a Randomized Clinical Trial

Context: This study was performed to evaluate the effects of genistein on metabolic and cardiovascular risk factors in Caucasian postmenopausal subjects with metabolic syndrome (MetS). Objective: Our objective was to assess the effects of genistein on surrogate endpoints associated with diabetes and cardiovascular disease. Design and Setting: This was a randomized, double-blind, placebo-controlled trial at 3 university medical centers in Italy. Patients: Patients included 120 postmenopausal women with MetS according to modified Third Report of the National Cholesterol Education Program (NCEP), Expert Panel on Detection, Evaluation and Treatment of High Blood Cholesterol in Adults (Adult Tre…

Valutazione semi-automatica dell’impregnazione post-contrastografica delle anse intestinali sede di malattia di Crohn, utilizzando diverse finestre temporali.

The Use of Lenograstim in the prevention of chemotherapy induced neutropenia in patiets with soft tissue sarcoma (STS)

Ruolo della Colangio-RM (1,5 T) nella valutazione delle complicanze post-chirurgiche in pazienti trattati con ERCP. Nostra esperienza